CoChat
Sign Up
Cited by 148Cutaneous Melanoma Detection and Managementmelanin and skin pigmentationAI in cancer detection

Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma

Altamura, Davide, Avramidis, Michelle, Menzies, Scott W.·2008·Archives of Dermatology
DOI 10.1001/archderm.144.4.502
Open this paper in CoChat — free account

Abstract

OBJECTIVE: To determine whether 6 weeks could replace 3 months for short-term sequential digital dermoscopy imaging (ST-SDDI) of suspicious melanocytic lesions and determine the proportion of melanomas missed. DESIGN: Consecutive lesions (n = 2602) undergoing ST-SDDI monitored from 1859 patients were included. Half of the patients underwent 6-week monitoring followed by 3-month monitoring (range, 2.5-4.5 months) if changes were not seen. The remainder underwent 3-month monitoring only. Any change during this time led to excision. Lesions unchanged were then followed up over time. SETTING: A tertiary referral institution. MAIN OUTCOME MEASURES: The proportion of changed melanomas (sensitivity) and odds ratios (ORs) for melanoma of changed lesions. RESULTS: Eighty-one melanomas were detected using ST-SDDI (Breslow thickness: median, in situ; maximum, 0.8 mm). Of 39 melanomas detected using ST-SDDI in the 6-week monitored lesions, 27 (69%) were detected at 6 weeks and 12 (31%) at 3 months. The OR for melanoma for a lesion changing at 6 weeks was 19 (95% confidence interval [CI], 10-35), and the overall OR for melanoma for a lesion changing during the short-term monitoring period (6 weeks to 4.5 months) was 47 (95% CI, 23-94). For lesions remaining unchanged at 3 months, 99.2% (1118 of 1127 lesions) were shown to be benign as defined by an unremarkable further follow-up. Seventy-five percent (15 of 20) of the lentigo maligna melanomas, 93% (40 of 43) of other in situ melanomas, and 96% (26 of 27) of the invasive melanomas were detected using ST-SDDI. Conclusion Three months remains the standard interval for ST-SDDI, where the sensitivity for the diagnosis of melanoma for changed (non-lentigo maligna) lesions is high but not 100%.

Integrity signals

Registry

Crossref · 10.1001/archderm.144.4.502

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Most false-negative melanomas are detected within three months of an initial negative index test, with a small number detected up to 12 months later.

    “This interval was chosen based on a study showing that most false-negative melanomas will be diagnosed within three months of the initial negative index test, although a small number will be diagnosed up to 12 months subsequently (Altamura 2008).”

    From Smartphone applications for triaging adults with skin lesions that are suspicious for melanoma (2018) · cites this paper as Altamura 2008

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Altamura, D., Avramidis, M., & Menzies, S. W.
Affiliations
  • Royal Prince Alfred Hospital (AU)
  • The University of Sydney (AU)
ORCID
Menzies, Scott W.
Venue
Archives of Dermatology
Publisher
American Medical Association (AMA)
Published
2008-04-01
Volume
144
Issue
4
Pages
502-6
ISSN
0003-987X (ISSN-L)
DOI
10.1001/archderm.144.4.502
OpenAlex
W2008378711
Cited by
148
References
14
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 5 · 2021: 8 · 2020: 12 · 2019: 5 · 2018: 13 · 2017: 7 · 2016: 14 · 2015: 7 · 2014: 6 · 2013: 10 · 2012: 19
FWCI
5.45
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Dermatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
Keywords
melanoma, melanocytic lesions, follow-up interval, sensitivity, lentigo maligna melanoma, melanoma in situ, invasive melanoma
MeSH terms
Artificial Intelligence, Carcinoma in Situ, Cell Transformation, Neoplastic, Dysplastic Nevus Syndrome, Follow-Up Studies, Humans, Image Processing, Computer-Assisted, Melanoma, Neoplasm Invasiveness, Sensitivity and Specificity, Skin, Skin Neoplasms, Software Design, Odds Ratio, Hutchinson's Melanotic Freckle, Dermoscopy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review